Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry
Journal of Business Ethics 105 (2):239-255 (2012)
| Abstract | The outsourcing of medical research has become a strategic imperative in the global pharmaceutical industry. Spurred by the challenges of competition, the need for speed in drug development, and increasing domestic costs, pharmaceutical companies across the globe continue to outsource critical parts of their value chain activities, namely contract clinical research and drug testing, to sponsors across the globe, typically into emerging markets. While it is clear that important ethical issues arise with this practice, unraveling moral responsibility and the allocation of responsibility is not so clear, considering that contracts, by their very definition transfer responsibility from the principal to the agent. This research provides a framework for exploring some of the ethical issues, including attributions of moral responsibility associated with Contract Medical Research. Using a theory of strategic and moral behavior, the research shows that both clients and sponsors in contract research have individual and collective responsibility to ensure that due care and diligence is exercised in the performance of clinical research. The research suggests some guidelines for stakeholder action. | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,653 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesSue Eckstein (ed.) (2003). Manual for Research Ethics Committees. Cambridge University Press.
Shaili Jain (2007). Understanding Physician-Pharmaceutical Industry Interactions. Cambridge University Press.
K. L. Phua & F. I. Achike (2007). Vioxx and Other Pharmaceutical Product Withdrawals: Ethical Issues in Ensuring the Integrity of Drug and Medical Device Research, Development and Commercialization. Clinical Ethics 2 (3):155-162.
Jennifer Susan Hawkins & Ezekiel J. Emanuel (2005). Clarifying Confusions About Coercion. Hastings Center Report 35 (5):16-19.
Onyeka K. Osuji & Okechukwu Timothy Umahi (2012). Pharmaceutical Companies and Access to Medicines – Social Integration and Ethical CSR Resolution of a Global Public Choice Problem. Journal of Global Ethics 8 (2-3):139-167.
Paul M. McNeill, Ian H. Kerridge, Catherine Arciuli, David A. Henry, Graham J. Macdonald, Richard O. Day & Suzanne R. Hill (2006). Gifts, Drug Samples, and Other Items Given to Medical Specialists by Pharmaceutical Companies. Journal of Bioethical Inquiry 3 (3).
David Finegold (ed.) (2005). Bioindustry Ethics. Elsevier Academic Press.
Murray Joseph Casey, Richard O.’Brien, Marc Rendell & Todd Salzman (2012). Ethical Dilemma of Mandated Contraception in Pharmaceutical Research at Catholic Medical Institutions. American Journal of Bioethics 12 (7):34 - 37.
Laurence J. Hirsch (2002). Conflicts of Interest in Drug Development: The Practices of Merck & Co., Inc. Science and Engineering Ethics 8 (3).
Jeremy Snyder, Valorie Crooks & Leigh Turner (2011). Issues and Challenges in Research on the Ethics of Medical Tourism: Reflections From a Conference. Journal of Bioethical Inquiry 8 (1):3-6.
Analytics
Monthly downloads |
Added to index2011-12-08Total downloads17 ( #70,994 of 548,984 )Recent downloads (6 months)1 ( #63,327 of 548,984 )How can I increase my downloads? |
My notes
Discussion
